Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Jayne

Showing results (1-10 of 340) with videos related to

Pageof 34
Sort By:
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2017
Vasculitis-when can biopsy be avoided?David Jayne
Nephrology (Carlton, Vic.)|October 27, 2004
Predictors of outcome in renal vasculitisDavid Jayne
Presse Medicale (Paris, France : 1983)|March 16, 2013
S2. Rituximab for ANCA-associated vasculitis: the UK experienceDavid Jayne
Journal of the American Society of Nephrology : JASN|September 19, 2008
Role of rituximab therapy in glomerulonephritisDavid Jayne
Nephrology (Carlton, Vic.)|April 2, 2009
Review article: Progress of treatment in ANCA-associated vasculitisDavid Jayne
The New England Journal of Medicine|November 6, 2014
Extending the indications for rituximab in ANCA-associated vasculitisDavid Jayne
Best Practice & Research. Clinical Rheumatology|June 11, 2009
The diagnosis of vasculitisDavid Jayne
APMIS. Supplementum|June 12, 2009
Treatment of ANCA-associated systemic small-vessel vasculitisDavid Jayne
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Rituximab treatment for vasculitisDavid Jayne
Kidney & Blood Pressure Research|September 25, 2003
Current attitudes to the therapy of vasculitisDavid Jayne
Pageof 34

Showing results (1-10 of 340) with videos related to

Sort By:
Pageof 34
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|October 24, 2017
Vasculitis-when can biopsy be avoided?David Jayne
Nephrology (Carlton, Vic.)|October 27, 2004
Predictors of outcome in renal vasculitisDavid Jayne
Presse Medicale (Paris, France : 1983)|March 16, 2013
S2. Rituximab for ANCA-associated vasculitis: the UK experienceDavid Jayne
Journal of the American Society of Nephrology : JASN|September 19, 2008
Role of rituximab therapy in glomerulonephritisDavid Jayne
Nephrology (Carlton, Vic.)|April 2, 2009
Review article: Progress of treatment in ANCA-associated vasculitisDavid Jayne
The New England Journal of Medicine|November 6, 2014
Extending the indications for rituximab in ANCA-associated vasculitisDavid Jayne
Best Practice & Research. Clinical Rheumatology|June 11, 2009
The diagnosis of vasculitisDavid Jayne
APMIS. Supplementum|June 12, 2009
Treatment of ANCA-associated systemic small-vessel vasculitisDavid Jayne
Clinical Journal of the American Society of Nephrology : CJASN|July 31, 2010
Rituximab treatment for vasculitisDavid Jayne
Kidney & Blood Pressure Research|September 25, 2003
Current attitudes to the therapy of vasculitisDavid Jayne
Pageof 34